Drack, Arlene
University of Iowa
2 papers on CoChatORCID 0000-0002-8195-8426
Most cited papers
- Verified
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet
Retinal Development and DisordersVirus-based gene therapy research
Cited by 1,952
- Verified · note
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease
Maguire, A. M., Russell, S., Chung, D. C., Yu, Z.-F., Tillman, A., Drack, A. V., Simonelli, F., Leroy, B. P., Reape, K. Z., High, K. A., et al. (2021) · Ophthalmology
Retinal Development and DisordersRetinal Diseases and Treatments
Cited by 194
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free